Pharmaceutical Executive - PharmExec
WEBPharmaceutical Executive-02-01-2022. ... Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
Evolving a Market Access Strategy to Improve Patient Access
WEBApr 29, 2021 · In the early stage (pre-clinical, Phase 1, 2a), market access teams can strategically pursue early payer feedback through health technology assessment (HTA) scientific advice to help the company understand how to position a new therapy for the best possible access outcomes.For example, the European Network for Health Technology Assessment (EUNETHTA) offers the option to pursue parallel payer ...
2022 Pharm Exec Top 50 Companies
WEBJun 9, 2022 · If 2020 was the “Year of COVID,” as we referred to it in our Pharm Exec 50 feature last year—reflecting on the pandemic’s scope and disruption on all facets of life—then 2021 was surely the year of COVID vaccines and treatments. And, through the prism of our latest rankings of the top 50 global biopharma players based on prescription drug sales, one that will go down in the annals of ...
The New Era of HCP Engagement: What’s Next on the Path to
WEBAug 17, 2021 · Perhaps surprisingly, the move to digital has improved the quality of engagements. HCP-rep interactions across Europe have increased in length from three minutes for a face-to-face meeting to 18 minutes in an online meeting on average. This allows more time to deliver in-depth and meaningful information. The …
Pharmaceutical Executive Editorial Staff - PharmExec
WEBPharmaceutical Executive Editorial Staff. January 10th 2024. Moderna’s vaccine revenue dropped from $18.4 billion in 2022 to $6.7 billion in 2023, however the company anticipates profitability this year powered by COVID-19 vaccine sales and the launch of its mRNA-based respiratory syncytial virus vaccine.
Site Activation: The Key to More Efficient Clinical Trials - PharmExec
WEBDec 12, 2008 · Patient enrollment, at its simplest, consists of three steps: Site selection. Site activation. Patient recruitment. Site selection is the process of identifying a sufficient number of and good-quality investigators to conduct the trial. This is one of the greatest challenges in clinical trial execution.
Turning the Corner: A New Era of Pharma Sales Comes Into View
WEBNov 9, 2021 · It found that 43% of HCPs felt that in-person meetings helped build trust, connection, a point-of-contact relationship, and communication that was more personalized and engaging. In addition, they could get samples and have better access to supporting material. On the contrary, 40% of HCPs didn’t like the longer time commitment, physical risk ...
China 2021 National Reimbursement Drug List Outlook - PharmExec
WEBNov 11, 2021 · The National Reimbursement Drug List (NRDL) is the major mechanism for public reimbursement in China, covering 98 percent of the entire population. Its formulary has been updated on a yearly basis since 2017, currently standing at 2,800 inclusions, compared to 2,588 in 2017. Most innovative drugs would strive to …
2021 Pharm Exec Top 50 Companies
WEBJun 9, 2021 · Manning the last two positions in the Pharma 50 top 10 are once again GlaxoSmithKline and Takeda. GSK, still planning to split the organization into two next year, recently announced plans to sell its complete stake in respiratory drug partner Innoviva (a royalty management company) for about $392 million.
Branding: When One is Not Enough - PharmExec
WEBFeb 3, 2016 · Ram Subramanian ([email protected]) is a director in the life sciences practice of Simon-Kucher & Partners based in Boston, MA. Dr. Rehan Baqri ([email protected]) is a consultant, also in the Boston office. The power of a second brand in the evolving global healthcare market, write Ram Subramanian and Dr. Rehan Baqri.